Safety and efficacy of daratumumab monotherapy in lupus nephritis refractory to conventional and rescue therapies

被引：0
|
作者：
Roccatello, Dario
Caniggia, Ilaria
Ceruti, Cecilia
Longo, Roberta
Nescis, Lorenzo
Sciascia, Savino
Fenoglio, Roberta
机构：
[1] Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, Nephrol & Dialysis Unit, Turin, Italy
[2] Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, Ctr Immuno Rheumatol & Rare Dis CMID, Turin, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.364
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
#2244
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EFFECTIVENESS AND SAFETY OF DARATUMUMAB IN MONOTHERAPY IN ADULT PATIENTS WITH RELAPSING AND REFRACTORY MULTIPLE MYELOMA (RRMM)
    Alarcon-Payer, C.
    Clavero Sanchez, M.
    Jimenez Morales, A.
    Salazar Bravo, M.
    Cornejo Calvo, M.
    Cano Dominguez, S.
    Rios Tamayo, R.
    Jurado Chacon, M.
    HAEMATOLOGICA, 2018, 103 : 122 - 122
  • [22] Efficacy and safety of belimumab in lupus nephritis: A retrospective study
    Zhang, Zhaowei
    Chen, Jiayin
    Du, Hongwei
    Hua, Li
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (05) : 196 - 203
  • [23] The safety and efficacy of MMF in lupus nephritis: a pilot study
    Kingdon, EJ
    McLean, AG
    Psimenou, E
    Davenport, A
    Powis, SH
    Sweny, P
    Burns, A
    LUPUS, 2001, 10 (09) : 606 - 611
  • [24] Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Usmani, Saad
    Weiss, Brendan
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk
    Voorhees, Peter M.
    Richardson, Paul G.
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2015, 126 (23)
  • [25] Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Weiss, Brendan M.
    Plesner, Torben
    Bahlis, Nizar J.
    Belch, Andrew
    Lonial, Sagar
    Lokhorst, Henk M.
    Voorhees, Peter M.
    Richardson, Paul G.
    Chari, Ajai
    Sasser, A. Kate
    Axel, Amy
    Feng, Huaibao
    Uhlar, Clarissa M.
    Wang, Jianping
    Khan, Imran
    Ahmadi, Tahamtan
    Nahi, Hareth
    BLOOD, 2016, 128 (01) : 37 - 44
  • [26] Efficacy and safety of rituximab biosimilar in refractory lupus
    Pongtarakulpanit, Nantakarn
    Pisitkun, Prapaporn
    Ngamjanyaporn, Pintip
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [27] Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
    Rovin, Brad H.
    Furie, Richard
    Latinis, Kevin
    Looney, R. John
    Fervenza, Fernando C.
    Sanchez-Guerrero, Jorge
    Maciuca, Romeo
    Zhang, David
    Garg, Jay P.
    Brunetta, Paul
    Appel, Gerald
    ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1215 - 1226
  • [28] Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
    D'Alessandro, Roberto
    Gonzalez, Estrella Garcia
    Frediani, Bruno
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (01)
  • [29] Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
    R Martínez
    A Muñoz
    M L Velloso
    S Rodríguez Montero
    M A Belmonte-López
    J L Marenco
    Journal of Translational Medicine, 8 (Suppl 1)
  • [30] Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial
    Tam, LS
    Li, EK
    Wong, CK
    Lam, CWK
    Li, WC
    Szeto, CC
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (03) : 417 - 418
12345